Diffusion of a new drug: A comparative analysis of adoption, treatment complexity, and persistence of risperidone long-acting injectable therapy in the Netherlands-Reference-Cited by-同舟云学术

Diffusion of a new drug: A comparative analysis of adoption, treatment complexity, and persistence of risperidone long-acting injectable therapy in the Netherlands

Published:2010-01 Issue:1 Volume:32 Page:108-118
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Pechlivanoglou Petros,Vehof Jelle,van Agthoven Michel,de Jong-van den Berg Lolkje T.W.,Postma Maarten J.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference31 articles.

1. The role of firm characteristics in pharmaceutical product launches;Kyle;RAND J Econ.,2006

2. Diffusion of new pharmaceutical drugs in developing and developed nations;Desiraju;Int J Res Market,2004

3. Information, learning, and drug diffusion: The case of cox-2 inhibitors;Chintagunta,2008

4. The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France;Olivier;Pharmacoepidemiol Drug Saf.,2006

5. Psychiatric decision making in the adoption of a new antipsychotic in Germany;Hamann;Psychiatr Serv.,2006

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Persistence with Injectable Therapy in Relapsing-Remitting Multiple Sclerosis: An 18-Year Observational Cohort Study;PLOS ONE;2015-04-13

2. Comparative Effectiveness of Risperidone Long-Acting Injectable vs First-Generation Antipsychotic Long-Acting Injectables in Schizophrenia: Results From a Nationwide, Retrospective Inception Cohort Study;Schizophrenia Bulletin;2014-09-01

3. Can authorities take advantage of the availability of generic atypical antipsychotic drugs? Findings from Sweden and potential implications;Journal of Pharmaceutical Health Services Research;2013-06-25

4. Are specific initiatives required to enhance prescribing of generic atypical antipsychotics in Scotland?: International implications;International Journal of Clinical Practice;2013-01-11

5. The cost–effectiveness of risperidone long-acting injection in the treatment of schizophrenia;Expert Review of Pharmacoeconomics & Outcomes Research;2012-06